REVIVE Webinar: Tackling pharmacokinetic and pharmacodynamic challenges in antifungal therapy

Speakers:

• Wan-Yu (Wendy) Chu, Postdoctoral researcher, Department of Pharmacy, Uppsala University (Sweden)
• Francelise Bridi Cavassin, Pharmacist, Faculdades Pequeno Príncipe (Brazil)
• David Andes, Professor, Division Chief Infectious Disease, University of Wisconsin-Madison (USA)

Moderator: Dallas Smith, Epidemiologist, Mycotic Diseases Branch, Centers for Disease Control and Prevention U.S. CDC (USA)

Fungal infections cause substantial morbidity and mortality globally. While antifungal resistance is on the rise, the current antifungal treatment options include a limited number of therapeutic classes which have many pharmacokinetic (PK) and pharmacodynamic (PD) challenges.

This webinar will host a expert discussions of recent advances to overcome PK and PD challenges for antifungal treatment.

• Presentation 1: Overcoming PK/PD issues with azoles: A fosravuconazole case study (Wendy (Wan-Yu) Chu)
• Presentation 2: The distinct pharmacokinetic profile of rezafungin (Francelise Bridi Cavassin)
• Presentation 3: Pharmacology of new antifungals (David Andes)

This webinar is done in collaboration with the Centers for Disease Control and Prevention U.S. CDC and will be broadcast during Fungal Awarness Week.

Date and time:
Thu, Sep 17, 2026 5:00 PM – 6:30 PM CEST

Dedicated registration link here